$1.3 Billion is the total value of Cormorant Asset Management, LP's 77 reported holdings in Q1 2022. The portfolio turnover from Q4 2021 to Q1 2022 was 21.8% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| TPTX | Buy | TURNING POINT THERAPEUTICS I | $99,345,000 | -31.2% | 3,700,000 | +22.3% | 7.63% | -11.1% |
| Buy | ERASCA INC | $90,348,000 | -44.8% | 10,505,554 | +0.0% | 6.94% | -28.7% | |
| DSGN | Sell | DESIGN THERAPEUTICS INC | $83,285,000 | -28.5% | 5,156,994 | -5.2% | 6.39% | -7.7% |
| RXDX | Sell | PROMETHEUS BIOSCIENCES INC | $68,853,000 | -5.8% | 1,823,444 | -1.3% | 5.29% | +21.6% |
| New | GREENLIGHT BIOSCIENCS HLDS P | $62,038,000 | – | 6,710,540 | +100.0% | 4.76% | – | |
| APLS | Buy | APELLIS PHARMACEUTICALS INC | $57,161,000 | +93.4% | 1,125,000 | +80.0% | 4.39% | +149.7% |
| RVMD | Sell | REVOLUTION MEDICINES INC | $50,894,000 | -16.9% | 1,995,066 | -18.0% | 3.91% | +7.3% |
| EWTX | Buy | EDGEWISE THERAPEUTICS INC | $45,424,000 | -16.6% | 4,682,874 | +31.3% | 3.49% | +7.6% |
| GLUE | MONTE ROSA THERAPEUTICS INC | $42,091,000 | -31.3% | 3,002,199 | 0.0% | 3.23% | -11.4% | |
| FMTX | Sell | FORMA THERAPEUTICS HLDGS INC | $37,836,000 | -42.7% | 4,068,351 | -12.3% | 2.90% | -26.0% |
| RNA | AVIDITY BIOSCIENCES INC | $37,164,000 | -22.3% | 2,012,115 | 0.0% | 2.85% | +0.3% | |
| TANGO THERAPEUTICS INC | $37,136,000 | -30.1% | 4,899,185 | 0.0% | 2.85% | -9.8% | ||
| AVTE | AEROVATE THERAPEUTICS INC | $33,557,000 | +55.5% | 1,830,691 | 0.0% | 2.58% | +100.6% | |
| HLXA | Buy | HELIX ACQUISITION CORP | $33,273,000 | +682.3% | 3,280,000 | +662.8% | 2.56% | +909.9% |
| TARS | Sell | TARSUS PHARMACEUTICALS INC | $23,144,000 | -26.7% | 1,375,982 | -1.9% | 1.78% | -5.4% |
| STOK | Sell | STOKE THERAPEUTICS INC | $22,898,000 | -19.3% | 1,087,807 | -8.0% | 1.76% | +4.2% |
| CNTA | CENTESSA PHARMACEUTICALS PLCsponsored ads | $22,334,000 | -20.3% | 2,489,894 | 0.0% | 1.72% | +2.8% | |
| CCXI | Buy | CHEMOCENTRYX INC | $21,686,000 | +48.9% | 865,000 | +116.2% | 1.66% | +92.3% |
| AXNX | AXONICS INC | $20,172,000 | +11.8% | 322,240 | 0.0% | 1.55% | +44.4% | |
| KRTX | New | KARUNA THERAPEUTICS INC | $19,018,000 | – | 150,000 | +100.0% | 1.46% | – |
| VRDN | Buy | VIRIDIAN THERAPEUTICS INC | $18,490,000 | +211.8% | 1,000,000 | +233.3% | 1.42% | +302.3% |
| VERV | Sell | VERVE THERAPEUTICS INC | $15,990,000 | -60.9% | 700,710 | -36.8% | 1.23% | -49.5% |
| BBIO | Sell | BRIDGEBIO PHARMA INC | $15,924,000 | -42.8% | 1,568,909 | -6.0% | 1.22% | -26.1% |
| ACET | ADICET BIO INC | $14,978,000 | +14.2% | 750,000 | 0.0% | 1.15% | +47.4% | |
| IMMUNEERING CORP | $14,898,000 | -60.0% | 2,302,626 | 0.0% | 1.14% | -48.4% | ||
| CYTK | Sell | CYTOKINETICS INC | $14,724,000 | -53.9% | 400,000 | -42.9% | 1.13% | -40.5% |
| BMEA | BIOMEA FUSION INC | $14,142,000 | -40.1% | 3,170,872 | 0.0% | 1.09% | -22.7% | |
| RCKT | ROCKET PHARMACEUTICALS INC | $13,775,000 | -27.3% | 868,550 | 0.0% | 1.06% | -6.2% | |
| PHVS | Sell | PHARVARIS N V | $12,420,000 | +25.1% | 684,888 | -0.7% | 0.95% | +61.7% |
| LBPH | LONGBOARD PHARMACEUTICALS IN | $12,139,000 | +9.7% | 2,273,221 | 0.0% | 0.93% | +41.6% | |
| ALXO | Sell | ALX ONCOLOGY HLDGS INC | $12,034,000 | -26.5% | 712,079 | -6.6% | 0.92% | -5.1% |
| RAIN | RAIN THERAPEUTICS INC | $11,796,000 | -60.6% | 2,326,660 | 0.0% | 0.91% | -49.2% | |
| TALS | Sell | TALARIS THERAPEUTICS INC | $11,559,000 | -36.1% | 1,174,723 | -0.7% | 0.89% | -17.5% |
| AVIR | Sell | ATEA PHARMACEUTICALS INC | $11,171,000 | -25.6% | 1,547,181 | -7.9% | 0.86% | -3.9% |
| GHRS | GH RESEARCH PLCordinary shares | $11,123,000 | -21.6% | 608,123 | 0.0% | 0.85% | +1.2% | |
| IGMS | Sell | IGM BIOSCIENCES INC | $10,751,000 | -26.7% | 402,200 | -19.6% | 0.82% | -5.4% |
| VENTYX BIOSCIENCES INC | $10,657,000 | -29.6% | 785,303 | 0.0% | 0.82% | -9.1% | ||
| HZNP | New | HORIZON THERAPEUTICS PUB L | $10,521,000 | – | 100,000 | +100.0% | 0.81% | – |
| AMAM | AMBRX BIOPHARMA INCsponsored ads | $10,244,000 | -54.4% | 2,486,386 | 0.0% | 0.79% | -41.0% | |
| BCAB | Buy | BIOATLA INC | $10,191,000 | -69.1% | 2,038,215 | +21.2% | 0.78% | -60.2% |
| VECT | Sell | VECTIVBIO HLDG AG | $9,790,000 | -10.1% | 2,078,485 | -6.2% | 0.75% | +16.2% |
| BHVN | New | BIOHAVEN PHARMACTL HLDG CO L | $9,486,000 | – | 80,000 | +100.0% | 0.73% | – |
| ITCI | New | INTRA CELLULAR THERAPIES INC | $9,178,000 | – | 150,000 | +100.0% | 0.70% | – |
| OLMA | Sell | OLEMA PHARMACEUTICALS INC | $8,869,000 | -56.3% | 2,082,000 | -4.0% | 0.68% | -43.6% |
| Sell | TYRA BIOSCIENCES INC | $8,105,000 | -30.2% | 757,432 | -9.8% | 0.62% | -9.9% | |
| PRAX | PRAXIS PRECISION MEDICINES I | $7,682,000 | -48.2% | 752,406 | 0.0% | 0.59% | -33.1% | |
| ASND | ASCENDIS PHARMA A/Ssponsored adr | $5,868,000 | -12.8% | 50,000 | 0.0% | 0.45% | +12.8% | |
| AKRO | AKERO THERAPEUTICS INC | $5,730,000 | -32.9% | 403,787 | 0.0% | 0.44% | -13.4% | |
| KROS | Sell | KEROS THERAPEUTICS INC | $5,438,000 | -38.0% | 100,000 | -33.3% | 0.42% | -19.9% |
| BEAM | Sell | BEAM THERAPEUTICS INC | $5,160,000 | -87.0% | 90,045 | -82.0% | 0.40% | -83.3% |
| ELDN | ELEDON PHARMACEUTICALS INC | $5,142,000 | -10.7% | 1,305,095 | 0.0% | 0.40% | +15.5% | |
| ELEV | ELEVATION ONCOLOGY INC | $4,998,000 | -58.1% | 1,983,165 | 0.0% | 0.38% | -45.9% | |
| New | VIGIL NEUROSCIENCE INC | $4,206,000 | – | 616,786 | +100.0% | 0.32% | – | |
| MRTX | Sell | MIRATI THERAPEUTICS INC | $4,111,000 | -62.6% | 50,000 | -33.3% | 0.32% | -51.7% |
| PLRX | PLIANT THERAPEUTICS INC | $3,382,000 | -48.1% | 482,413 | 0.0% | 0.26% | -32.8% | |
| ITOS | Sell | ITEOS THERAPEUTICS INC | $3,218,000 | -53.9% | 100,000 | -33.3% | 0.25% | -40.5% |
| ICOSAVAX INC | $3,002,000 | -69.2% | 426,393 | 0.0% | 0.23% | -60.3% | ||
| New | GELESIS HLDGS INC | $2,751,000 | – | 626,108 | +100.0% | 0.21% | – | |
| PYXIS ONCOLOGY INC | $2,702,000 | -62.0% | 668,854 | 0.0% | 0.21% | -51.1% | ||
| HARP | HARPOON THERAPEUTICS INC | $2,687,000 | -34.2% | 540,600 | 0.0% | 0.21% | -15.2% | |
| BCEL | Buy | ATRECA INC | $2,536,000 | +205.9% | 800,000 | +192.5% | 0.20% | +298.0% |
| CABA | CABALETTA BIO INC | $2,343,000 | -46.4% | 1,154,424 | 0.0% | 0.18% | -30.8% | |
| GLTO | GALECTO INC | $2,245,000 | -27.4% | 1,020,238 | 0.0% | 0.17% | -6.5% | |
| RENOVACOR INC | $2,120,000 | -44.9% | 500,000 | 0.0% | 0.16% | -28.8% | ||
| MGTX | MEIRAGTX HLDGS PLC | $2,078,000 | -41.6% | 150,000 | 0.0% | 0.16% | -24.5% | |
| Sell | ASTRIA THERAPEUTICS INC | $2,013,000 | -32.4% | 300,000 | -45.7% | 0.16% | -12.4% | |
| AKUS | AKOUOS INC | $1,874,000 | -44.1% | 394,500 | 0.0% | 0.14% | -27.6% | |
| YMAB | Sell | Y-MABS THERAPEUTICS INC | $1,782,000 | -63.4% | 150,000 | -50.0% | 0.14% | -52.6% |
| GOSS | GOSSAMER BIO INC | $1,722,000 | -23.3% | 198,382 | 0.0% | 0.13% | -0.8% | |
| AUTL | AUTOLUS THERAPEUTICS PLCspon ads | $1,635,000 | -19.7% | 392,167 | 0.0% | 0.13% | +4.1% | |
| CMMB | New | CHEMOMAB THERAPEUTICS LTDsponsored ads | $1,383,000 | – | 288,168 | +100.0% | 0.11% | – |
| ANAB | Sell | ANAPTYSBIO INC | $1,237,000 | -64.4% | 50,000 | -50.0% | 0.10% | -54.1% |
| DTIL | PRECISION BIOSCIENCES INC | $1,067,000 | -58.4% | 346,524 | 0.0% | 0.08% | -46.4% | |
| GRPH | GRAPHITE BIO INC | $1,036,000 | -59.0% | 203,153 | 0.0% | 0.08% | -46.7% | |
| IMV | IMV INC | $337,000 | +16.6% | 234,374 | 0.0% | 0.03% | +52.9% | |
| XFOR | X4 PHARMACEUTICALS INC | $182,000 | -23.5% | 103,980 | 0.0% | 0.01% | 0.0% | |
| ORTX | ORCHARD THERAPEUTICS PLCads | $183,000 | -46.0% | 256,649 | 0.0% | 0.01% | -30.0% | |
| OTLKW | Exit | OUTLOOK THERAPEUTICS INC*w exp 02/18/202 | $0 | – | -270,698 | -100.0% | -0.00% | – |
| Exit | SONENDO INC | $0 | – | -149,200 | -100.0% | -0.05% | – | |
| CNTB | Exit | CONNECT BIOPHARMA HLDGS LTDads | $0 | – | -200,000 | -100.0% | -0.06% | – |
| QURE | Exit | UNIQURE NV | $0 | – | -50,000 | -100.0% | -0.06% | – |
| MRUS | Exit | MERUS N V | $0 | – | -100,000 | -100.0% | -0.19% | – |
| CLDX | Exit | CELLDEX THERAPEUTICS INC NEW | $0 | – | -100,000 | -100.0% | -0.23% | – |
| ALGS | Exit | ALIGOS THERAPEUTICS INC | $0 | – | -521,257 | -100.0% | -0.37% | – |
| ZYME | Exit | ZYMEWORKS INC | $0 | – | -600,000 | -100.0% | -0.58% | – |
| ACRS | Exit | ACLARIS THERAPEUTICS INC | $0 | – | -900,000 | -100.0% | -0.78% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-05-16
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| QUOTIENT LTD | 30 | Q3 2021 | 4.3% |
| ASCENDIS PHARMA A/S | 30 | Q4 2022 | 4.8% |
| MINERVA NEUROSCIENCES INC | 29 | Q3 2021 | 4.4% |
| ACCELERON PHARMA INC | 28 | Q2 2021 | 3.4% |
| OMEROS CORP | 27 | Q3 2021 | 6.5% |
| MIRATI THERAPEUTICS INC | 25 | Q4 2022 | 7.6% |
| BLUEPRINT MEDICINES CORP | 25 | Q3 2021 | 3.6% |
| APELLIS PHARMACEUTICALS INC | 24 | Q3 2023 | 8.6% |
| NEUROCRINE BIOSCIENCES INC | 24 | Q1 2020 | 4.6% |
| ROCKET PHARMACEUTICALS, INC | 23 | Q3 2023 | 2.4% |
View Cormorant Asset Management, LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Ambrx Biopharma Inc. | March 13, 2023 | 42,771,365 | - |
| Altimmune, Inc. | February 14, 2023 | 2,600,000 | - |
| Arcellx, Inc. | February 14, 2023 | 2,075,000 | - |
| BioAtla, Inc. | February 14, 2023 | 2,499,250 | - |
| Eledon Pharmaceuticals, Inc. | February 14, 2023 | 1,391,663 | - |
| GreenLight Biosciences Holdings, PBC | February 14, 2023 | 4,751,020 | - |
| Prometheus Biosciences, Inc. | February 14, 2023 | 700,000 | - |
| Tango Therapeutics, Inc. | February 14, 2023 | 1,000,000 | - |
| VectivBio Holding AG | February 14, 2023 | 1,515,087 | - |
| Viridian Therapeutics, Inc.\DE | February 14, 2023 | 1,100,000 | - |
View Cormorant Asset Management, LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 4 | 2024-04-22 |
| SC 13G/A | 2024-04-15 |
| 4 | 2024-04-03 |
| SC 13G | 2024-03-21 |
| 4 | 2024-03-18 |
| SC 13G/A | 2024-03-18 |
| 4 | 2024-03-11 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
View Cormorant Asset Management, LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.